PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS
1 total filings · 0 classes · Active since Oct 2025
PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 42 (Science & Technology) with 1 filings. The WikiTrademarks Expansion Score is 4/100, low — the brand is focused on defending its existing categories rather than expanding.
USPTO data refreshed June 21, 2026
Own this brand? Claim the profile to add your logo, story, and website.
Sign in to claimHow is PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS filing trademarks, and where is the portfolio expanding?
Filing Velocity (24 Months)
Filing Activity by NICE Class
Nice Class Distribution
Activity Timeline
No activity recorded yet.
Recent Filings
| Serial No. | Mark | Filing Date | Status | Classes | Owner |
|---|---|---|---|---|---|
| 99469347 | PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS | Oct 29, 2025 | Registered | 042 Science & Technology | Duke University |
Weekly visibility reports showing how ChatGPT mentions PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.
FAQ: PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS trademark portfolio
What trademarks does PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS hold?
PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 42 (Science & Technology). The most recent filings are registered to Duke University.
How many trademarks does PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS have at the USPTO?
WikiTrademarks tracks 1 USPTO trademark filings attributed to PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS. The brand has been actively filing since October 2025. The count updates daily as new filings are indexed from the USPTO bulk data feed.
In which NICE classes does PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS file most often?
PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS's most active class is NICE Class 42 (Science & Technology), with 1 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.
Who owns the PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS trademark?
The most recent filings under the PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS mark are registered to Duke University. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.
Is PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS expanding into new categories?
The current WikiTrademarks Expansion Score for PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS is 4 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.
How can I track new PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS trademark filings?
Click the Watch Brand button at the top of this page to add PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.
More on this portfolio: Compare PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS to another owner · Browse all NICE classes · Most valuable brands
Community notes
0 notesShare what you know about PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS and help the next person researching it.